These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1734906)
1. Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drug. Hirohata S; Shinohara S; Inoue T; Miyamoto T; Lipsky PE Arthritis Rheum; 1992 Feb; 35(2):168-75. PubMed ID: 1734906 [TBL] [Abstract][Full Text] [Related]
2. Regulation of in vitro anti-DNA antibody production by a novel disease modifying anti-rheumatic drug, Lobenzarit. Hirohata S Clin Exp Rheumatol; 1992; 10(4):357-63. PubMed ID: 1356678 [TBL] [Abstract][Full Text] [Related]
3. Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug. Hirohata S; Lipsky PE Clin Immunol Immunopathol; 1993 Jan; 66(1):43-51. PubMed ID: 8440072 [TBL] [Abstract][Full Text] [Related]
4. Frequency analysis of human peripheral blood B cells producing IgM-rheumatoid factor. Differential effects of stimulation with monoclonal antibodies to CD3 and Staphylococcus aureus. Hirohata S; Inoue T; Miyamoto T J Immunol; 1990 Sep; 145(6):1681-6. PubMed ID: 2144005 [TBL] [Abstract][Full Text] [Related]
5. Selective induction of IgM rheumatoid factors by CD14+ monocyte-lineage cells generated from bone marrow of patients with rheumatoid arthritis. Hirohata S; Yanagida T; Koda M; Koiwa M; Yoshino S; Ochi T Arthritis Rheum; 1995 Mar; 38(3):384-8. PubMed ID: 7880194 [TBL] [Abstract][Full Text] [Related]
6. Immunopharmacological study of CCA (Lobenzarit disodium), an anti-arthritis agent--I. Abrogation of IL 1 secretion by LPS-stimulated human monocytes and induction of gamma-interferon production with CCA. Fujimoto M; Sugawara I; Kimoto M; Ishizaka S; Tsujii T Int J Immunopharmacol; 1986; 8(3):323-8. PubMed ID: 3089953 [TBL] [Abstract][Full Text] [Related]
7. Lobenzarit disodium (CCA) inhibits in vitro immunoglobulin production via direct interaction with B lymphocytes. Takeda Y; Urakawa K; Sakamoto A; Nakano T; Sugawara Y; Ohsugi Y; Morita M; Kasahara T Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):177-81. PubMed ID: 1576670 [TBL] [Abstract][Full Text] [Related]
8. T cell regulation of in vitro IgM-rheumatoid factor production by normal human B cells. Differential effects of stimulation with immobilized monoclonal antibodies to CD3 and Staphylococcus aureus. Hirohata S; Inoue T; Miyamoto T Arerugi; 1990 Feb; 39(2 Pt 1):82-9. PubMed ID: 2141251 [TBL] [Abstract][Full Text] [Related]
9. Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells. Hirohata S; Lipsky PE Arthritis Rheum; 1994 Jun; 37(6):942-50. PubMed ID: 8003068 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human B cell activation by a novel nonsteroidal anti-inflammatory drug, indometacin famesil. Hirohata S; Yanagida T; Kawai M; Kikuchi H Immunopharmacology; 1999 Nov; 44(3):245-54. PubMed ID: 10598881 [TBL] [Abstract][Full Text] [Related]
11. An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice. Mihara M; Nakano T; Ohsugi Y Clin Immunol Immunopathol; 1987 Dec; 45(3):366-74. PubMed ID: 3500002 [TBL] [Abstract][Full Text] [Related]
12. IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells. Callaghan M; Whelan A; Feighery C; Bresnihan B Clin Exp Immunol; 1993 Aug; 93(2):212-7. PubMed ID: 8348746 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of expression of cyclin A in human B cells by an immunosuppressant mizoribine. Hirohata S; Yanagida T J Immunol; 1995 Dec; 155(11):5175-83. PubMed ID: 7594527 [TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of human B cell activation by gold sodium thiomalate and auranofin. Hirohata S; Nakanishi K; Yanagida T; Kawai M; Kikuchi H; Isshi K Clin Immunol; 1999 May; 91(2):226-33. PubMed ID: 10227815 [TBL] [Abstract][Full Text] [Related]
15. CCA (disodium 4-chloro-2,2'-iminodibenzoate) inhibits progression of human T cell proliferation triggered by PHA. Katagiri K; Nakano T; Sugawara Y; Ichikawa Y; Yoshida T Clin Immunol Immunopathol; 1990 Sep; 56(3):384-92. PubMed ID: 2118015 [TBL] [Abstract][Full Text] [Related]
16. Frequency analysis of human peripheral blood B cells producing autoantibodies: differential activation requirements of precursors for B cells producing IgM-RF and anti-DNA antibody. Hirohata S; Inoue T; Ito K Cell Immunol; 1991 Dec; 138(2):445-55. PubMed ID: 1834351 [TBL] [Abstract][Full Text] [Related]
17. IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis. Hidaka T; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishizuka T; Kawagoe M; Nakamura H Clin Exp Immunol; 1992 Aug; 89(2):223-9. PubMed ID: 1379131 [TBL] [Abstract][Full Text] [Related]
19. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes. Lorber M; Samuel D; Amlot P; Panayi GS Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207 [TBL] [Abstract][Full Text] [Related]
20. In vitro IgM and IgM rheumatoid factor production in response to Staphylococcus aureus Cowan I: evidence for the role of Leu-2-positive T suppressor cells and radiosensitive T helper cells. Goldstein R; Perelmutter L; Karsh J Clin Exp Immunol; 1987 Aug; 69(2):358-67. PubMed ID: 2958196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]